Symptom Information: Sort according to HPO 

1
(HPO:0000098) Tall stature 74 / 7739
2
(HPO:0000278) Retrognathia 100 / 7739
3
(HPO:0000494) Downslanted palpebral fissures 328 / 7739
4
(HPO:0001250) Seizures 1245 / 7739
5
(HPO:0001254) Lethargy 104 / 7739
6
(HPO:0001263) Global developmental delay 853 / 7739
7
(HPO:0001274) Agenesis of corpus callosum 142 / 7739
8
(HPO:0001321) Cerebellar hypoplasia 114 / 7739
9
(HPO:0001347) Hyperreflexia 363 / 7739
10
(HPO:0002415) Leukodystrophy 30 / 7739
11
(HPO:0006829) Severe muscular hypotonia 29 / 7739
12
(HPO:0007291) Posterior fossa cyst 10 / 7739
13
(OMIM) Retrognathia, mild 3 / 7739
14
(OMIM) Refractory seizures 15 / 7739
15
(OMIM) Tonic posturing 1 / 7739
16
(OMIM) Abnormal gyri 3 / 7739
17
(OMIM) High pitched cry 5 / 7739
18
(OMIM) Increased gamma-aminobutyric acid in plasma, urine, and cerebrospinal fluid (CSF) 1 / 7739
19
(OMIM) Increased beta-alanine (in 1 of 2 patients) 1 / 7739
20
(OMIM) Increased growth hormone (in 1 of 2 patients) 1 / 7739
21
(OMIM) Decreased hepatic GABA transaminase activity 1 / 7739
22
(OMIM) Early death 13 / 7739
23
(HPO:0000007) Autosomal recessive inheritance 2538 / 7739
24
(HPO:0003819) Death in childhood 42 / 7739